Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.470
+0.060 (4.26%)
At close: May 12, 2025, 4:00 PM
1.520
+0.050 (3.37%)
After-hours: May 12, 2025, 7:40 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $90.24 million as of May 12, 2025. Its market cap has decreased by -87.43% in one year.
Market Cap
90.24M
Enterprise Value
-158.92M
1-Year Change
-87.43%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $90.24M, a decrease of -87.77%. That is a compound annual growth rate of -34.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 86.55M | -89.20% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |